Pregnancy and Childbirth
Conditions
Interventions
Treatment Group A carbetocin
Treatment Group B oxytocin
Sponsors
University of Ilorin TETFUND Institution Based Research
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Consenting women above 18 years undergoing spontaneous vaginal delivery at term in a vertex presenting fetus
Exclusion criteria
Exclusion criteria: a. grandmultiparity, b. anemia in pregnancy, c. antepartum haemorrhage in index pregnancy, d. asymptomatic placenta praevia, e. multiple pregnancy, f. co-existing uterine fibroid, g. polyhydramnious and h. previous scar
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine incidence of PPH (blood loss > 500 ml following vaginal delivery) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Incidence of maternal side effects (nausea, vomiting, allergic reactions, ……..) 2. Incidence of retained placenta 3. Incidence of secondary postpartum haemorrhage 4. Incidence of maternal hypotension 5. Need for additional uterotonics 6. Change in haematocrit (pre delivery versus post delivery) 7. Need for blood transfusion 8. Need for surgical intervention (examination under anaethesia, B-lynch sutures, subtotal hysterectomy) 9. Length of hospital stay 10. Incidence of maternal death | — |
Countries
Nigeria
Contacts
Public ContactSadiya Musa Gwadabe
Dr. University of Ilorin
Outcome results
None listed